Literature DB >> 9737685

Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals.

L J Bendall1, V Makrynikola, A Hutchinson, A C Bianchi, K F Bradstock, D J Gottlieb.   

Abstract

Acute myeloid leukaemia (AML) cells express the SCF receptor c-kit (CD117) on their cell surface and demonstrate enhanced adhesion to fibronectin (FN) following exposure to stem cell factor (SCF). Increased adhesion occurs within 5 min, is dose dependent, and persists beyond 2 h. Baseline and enhanced adhesion occur through the surface FN receptor very late antigen-5 (VLA-5, CD49e/CD29) which is expressed by AML cells. Unstimulated AML cells exposed to FN undergo less apoptosis than controls (inhibition 22.5 +/- 7.0%, P = 0.02, n = 8). Exposure to SCF alone without FN also inhibits AML cell apoptosis (by 19.0 +/- 7.7% compared to controls, P = 0.06, n = 8). Simultaneous exposure to SCF and FN increases the inhibition of AML cell apoptosis to 37.8 +/- 7.9% (P = 0.005 compared to control, P = 0.04 compared to FN alone, P = 0.06 compared to SCF alone) demonstrating that SCF not only enhances the propensity of AML cells to adhere to FN, but also results in an additive survival benefit following FN contact. Some but not all the reduction in apoptosis is mediated through VLA-5. The combination of SCF and FN also affects proliferation, resulting in a synergistic enhancement of AML cell proliferation in half the cases studied. When normal CD34+ human haemopoietic progenitors were studied, FN had little effect on their apoptosis and failed to enhance the anti-apoptotic effect of SCF. It did, however, synergise with SCF in promoting CD34+ cell proliferation. Exposure of AML cells to SCF and FN, both of which can be found in high concentration in the bone marrow stroma, inhibits apoptosis. Cytokines and extracellular matrix proteins augment each others' effects since SCF enhances adhesion to fibronectin, which in turn augments the survival signal delivered by the cytokine alone. Cytokine and adhesion receptors can combine to affect cell characteristics including proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737685     DOI: 10.1038/sj.leu.2401136

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

1.  A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.

Authors:  Geoffrey L Uy; Michael P Rettig; Ibraheem H Motabi; Kyle McFarland; Kathryn M Trinkaus; Lindsay M Hladnik; Shashikant Kulkarni; Camille N Abboud; Amanda F Cashen; Keith E Stockerl-Goldstein; Ravi Vij; Peter Westervelt; John F DiPersio
Journal:  Blood       Date:  2012-02-02       Impact factor: 22.113

2.  Functional and structural insights into ASB2alpha, a novel regulator of integrin-dependent adhesion of hematopoietic cells.

Authors:  Isabelle Lamsoul; Clara F Burande; Ziba Razinia; Thibault C Houles; Delphine Menoret; Massimiliano Baldassarre; Monique Erard; Christel Moog-Lutz; David A Calderwood; Pierre G Lutz
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

3.  Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines.

Authors:  Guenadi Kouniavsky; Marat Khaikin; Isabel Zvibel; Dov Zippel; Shlomo Brill; Zamir Halpern; Moshe Papa
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 4.  Targeting the c-kit receptor in the treatment of acute myelogenous leukemia.

Authors:  Anjali S Advani
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

5.  Covalent immobilization of stem cell factor and stromal derived factor 1α for in vitro culture of hematopoietic progenitor cells.

Authors:  Maude L Cuchiara; Kelsey L Horter; Omar A Banda; Jennifer L West
Journal:  Acta Biomater       Date:  2013-08-17       Impact factor: 8.947

6.  Establishment of a xenograft model of human myelodysplastic syndromes.

Authors:  Yukari Muguruma; Hiromichi Matsushita; Takashi Yahata; Shizu Yumino; Yumiko Tanaka; Hayato Miyachi; Yoshiaki Ogawa; Hiroshi Kawada; Mamoru Ito; Kiyoshi Ando
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

7.  Induction of hypoxia-inducible factor-1α inhibits drug-induced apoptosis in the human leukemic cell line HL-60.

Authors:  Yeon-Joo Yook; Young-Jin Seo; Hyoung Jin Kang; Sang-Hyeok Ko; Hee Young Shin; Jeong Jin Lee; Gajin Jeong; Hyo Seop Ahn
Journal:  Korean J Hematol       Date:  2010-09-30

Review 8.  Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells.

Authors:  Mary E Gerritsen; James E Tomlinson; Constance Zlot; Michael Ziman; Stuart Hwang
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

9.  Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.

Authors:  Andrew J Mhyre; A Mario Marcondes; Emily Y Spaulding; H Joachim Deeg
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

Review 10.  Novel postremission strategies in adults with acute myeloid leukemia.

Authors:  Jeffrey E Lancet; Judith E Karp
Journal:  Curr Opin Hematol       Date:  2009-03       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.